exo-N-(2-(4-azidotetrafluorobenzamido)ethyl)-deoxycytidine-5'-triphosphate: structure given in first source [MeSH]
ID Source | ID |
---|---|
PubMed CID | 3036126 |
MeSH ID | M0209282 |
Synonym |
---|
exo-n-(2-(4-azidotetrafluorobenzamido)ethyl)-deoxycytidine-5'-triphosphate |
145278-12-2 |
cytidine 5'-(tetrahydrogen triphosphate), n-(2-((4-azido-2,3,5,6-tetrafluorobenzoyl)amino)ethyl)-2'-deoxy- |
exo-n-(2-(p-azidotetrafluorobenzamido)ethyl)-deoxycytidine-5'-triphosphate |
fabdctp |
[[(2r,3s,5r)-5-[4-[2-[(4-azido-2,3,5,6-tetrafluorobenzoyl)amino]ethylamino]-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate |
DTXSID10162961 |
exo-n-(2-(4-azidotetrafluorobenzamido)ethyl)-deoxycytidine-5/'-triphosphate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
thymidine monophosphate | thymidine 5'-monophosphate | fundamental metabolite | 1996 | 1996 | 28.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
deoxycytidine monophosphate | 2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate | Escherichia coli metabolite; mouse metabolite | 1996 | 1996 | 28.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
azides | pseudohalide anion | mitochondrial respiratory-chain inhibitor | 1998 | 1998 | 26.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
thymidine 5'-triphosphate | pyrimidine 2'-deoxyribonucleoside 5'-triphosphate; thymidine phosphate | Escherichia coli metabolite; mouse metabolite | 1996 | 1996 | 28.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
2'-deoxycytidine 5'-triphosphate | 2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate | Escherichia coli metabolite; human metabolite; mouse metabolite | 1994 | 1998 | 28.0 | high | 0 | 0 | 2 | 0 | 0 | 0 | |
phosphorus | monoatomic phosphorus; nonmetal atom; pnictogen | macronutrient | 1998 | 1998 | 26.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
phosphorus radioisotopes | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 |
Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HIV | 0 | 1994 | 1994 | 30.0 | high | 0 | 0 | 1 | 0 | 0 | 0 |